US Stock MarketDetailed Quotes
RQHTF RELIQ HEALTH TECHNOLOGIES INC
- 0.001100
- 0.0000000.00%
15min DelayClose Nov 27 16:00 ET
216.44KMarket Cap-73P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.001100Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)196.76MShares0.29140052wk High0.04P/B216.44KFloat Cap0.00000152wk Low--Dividend TTM196.76MShs Float1.034400Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
RELIQ HEALTH TECHNOLOGIES INC Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (Q3)Mar 31, 2021 | (Q2)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 115.91%3.47M | 484.87%8.55M | 470.04%2.29M | 469.03%2.52M | 412.22%2.14M | 700.47%1.61M | 27.92%1.46M | 3,311.49%401.46K | -3.30%441.99K | 4.24%417.81K |
| Operating revenue | 115.91%3.47M | 444.75%8.77M | 348.70%2.47M | 469.03%2.52M | 422.50%2.18M | 700.47%1.61M | 40.90%1.61M | 4,572.20%549.83K | -3.30%441.99K | 4.24%417.81K |
| Cost of revenue | 188.91%1.3M | 437.97%3.25M | 2,867.11%1.37M | 249.21%878.91K | 178.50%556.42K | 295.08%449.14K | -37.62%604.21K | -79.61%46.04K | -19.96%251.69K | -34.91%199.79K |
| Gross profit | 87.62%2.17M | 517.90%5.3M | 159.54%922.47K | 759.75%1.64M | 626.40%1.58M | 1,228.88%1.16M | 392.07%857.95K | 266.05%355.43K | 33.43%190.3K | 132.23%218.02K |
| Operating expense | -46.22%2.9M | 8.86%13.6M | -12.32%2.17M | -17.41%2.42M | -19.55%3.61M | 108.45%5.4M | 10.14%12.49M | 63.63%2.48M | -1.95%2.93M | 6.89%4.48M |
| Selling and administrative expenses | -60.45%2.07M | -1.00%10.52M | -61.02%744.37K | -49.97%1.35M | -18.91%3.19M | 156.28%5.24M | 15.88%10.63M | 15.77%1.91M | 9.58%2.69M | 24.94%3.93M |
| -Selling and marketing expense | -85.51%16.36K | -4.47%492.65K | -82.47%74.92K | 328.22%101.56K | 1,922.50%203.3K | 1,956.54%112.86K | 45.89%515.7K | 1,196.02%427.38K | -89.07%23.72K | -86.60%10.05K |
| -General and administrative expense | -59.90%2.06M | -0.82%10.03M | -54.83%669.45K | -53.33%1.25M | -23.89%2.98M | 151.44%5.13M | 14.68%10.11M | -8.30%1.48M | 19.13%2.67M | 27.66%3.92M |
| Research and development costs | 529.36%801.18K | 28.31%2.22M | 41.73%655.99K | 358.07%1.05M | -25.02%394.03K | -75.31%127.3K | 0.45%1.73M | 1,058.78%462.83K | -30.82%228.17K | -40.74%525.5K |
| Depreciation amortization depletion | 3.10%27.76K | -8.32%115.29K | -65.38%34.9K | 249.19%26.66K | -7.55%26.8K | -3.12%26.93K | -71.77%125.76K | 216.95%100.8K | -96.18%7.64K | -82.20%28.99K |
| -Depreciation and amortization | 3.10%27.76K | -8.32%115.29K | -65.38%34.9K | 249.19%26.66K | -7.55%26.8K | -3.12%26.93K | -71.77%125.76K | 216.95%100.8K | -96.18%7.64K | -82.20%28.99K |
| Provision for doubtful accounts | ---- | 12,994.16%738.25K | ---- | ---- | ---- | ---- | --5.64K | ---- | ---- | ---- |
| Operating profit | 82.83%-727.85K | 28.69%-8.3M | 41.08%-1.25M | 71.40%-783.4K | 52.57%-2.02M | -69.39%-4.24M | -4.18%-11.63M | -22.81%-2.12M | 3.73%-2.74M | -4.02%-4.27M |
| Net non-operating interest income expense | 857.87%75.13K | 188.65%41.33K | 405.06%68.47K | 50.74%-8.11K | -6.25%-9.12K | -13.37%-9.91K | -28.81%-46.62K | 7.52%-22.44K | -44.87%-16.46K | -1,827.87%-8.58K |
| Non-operating interest income | --80.79K | --76.61K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Non-operating interest expense | -42.88%5.66K | -24.32%35.28K | -63.72%8.14K | -50.74%8.11K | 6.25%9.12K | 13.37%9.91K | 28.81%46.62K | -7.52%22.44K | 44.87%16.46K | 1,827.87%8.58K |
| Other net income (expense) | 1,298.59%530.25K | 182.45%83.44K | 298.85%187.67K | 54.29%-19.54K | -430.74%-122.61K | 3,411.18%37.91K | -226.82%-101.19K | -595.39%-94.38K | -1,725.13%-42.74K | -56.09%37.07K |
| Gain on sale of security | 1,298.59%530.25K | 182.45%83.44K | 298.85%187.67K | 54.29%-19.54K | -430.74%-122.61K | 3,411.18%37.91K | -324.35%-101.19K | -201.08%-94.38K | -1,725.13%-42.74K | 1,104.35%37.07K |
| Income before tax | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 71.02%-811.04K | 49.14%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 1.95%-2.8M | -5.49%-4.24M |
| Income tax | ||||||||||
| Net income | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 71.02%-811.04K | 49.14%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 1.95%-2.8M | -5.49%-4.24M |
| Net income continuous Operations | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 71.02%-811.04K | 49.14%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 1.95%-2.8M | -5.49%-4.24M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 71.02%-811.04K | 49.14%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 1.95%-2.8M | -5.49%-4.24M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 71.02%-811.04K | 49.14%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 1.95%-2.8M | -5.49%-4.24M |
| Basic earnings per share | 95.00%-0.001 | 42.86%-0.04 | 0 | 50.00%-0.01 | 66.67%-0.01 | 33.33%-0.02 | 12.50%-0.07 | 66.67%-0.01 | 0.00%-0.02 | 0.00%-0.03 |
| Diluted earnings per share | 95.00%-0.001 | 42.86%-0.04 | 0 | 50.00%-0.01 | 66.67%-0.01 | 33.33%-0.02 | 12.50%-0.07 | 66.67%-0.01 | 0.00%-0.02 | 0.00%-0.03 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data